{"id":104005,"date":"2026-04-08T00:29:51","date_gmt":"2026-04-07T22:29:51","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=104005"},"modified":"2026-04-07T18:05:04","modified_gmt":"2026-04-07T16:05:04","slug":"budoucnost-farmacie-jak-miliardove-spojenectvi-eli-lilly-a-insilico-predefinuje-vyvoj-leciv","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2026\/04\/08\/budoucnost-farmacie-jak-miliardove-spojenectvi-eli-lilly-a-insilico-predefinuje-vyvoj-leciv\/","title":{"rendered":"Budoucnost farmacie: Jak miliardov\u00e9 spojenectv\u00ed Eli Lilly a Insilico p\u0159edefinuje v\u00fdvoj l\u00e9\u010div?"},"content":{"rendered":"
<\/div>\n

\u00c9ra n\u00e1hodn\u00e9ho objevov\u00e1n\u00ed molekul a zdlouhav\u00fdch laboratorn\u00edch experiment\u016f metodou pokus-omyl se definitivn\u011b ch\u00fdl\u00ed ke konci. Strategick\u00e1 investice farmaceutick\u00e9ho giganta Eli Lilly do partnerstv\u00ed se spole\u010dnost\u00ed Insilico Medicine v celkov\u00e9 hodnot\u011b 2,75 miliardy USD potvrzuje, \u017ee generativn\u00ed um\u011bl\u00e1 inteligence se st\u00e1v\u00e1 srdcem modern\u00edho farmaceutick\u00e9ho v\u00fdzkumu. Toto spojen\u00ed glob\u00e1ln\u00ed distribu\u010dn\u00ed s\u00edly a technologick\u00e9 p\u0159evahy vytv\u00e1\u0159\u00ed nov\u00fd pr\u016fmyslov\u00fd standard, kter\u00fd slibuje zkr\u00e1tit v\u00fdvoj l\u00e9\u010div z let na pouh\u00e9 m\u011bs\u00edce.<\/p>\n

S\u00e1zka na re\u00e1ln\u00e9 v\u00fdsledky<\/strong><\/h3>\n

D\u016fv\u011bra spole\u010dnosti Eli Lilly v technologii Insilico je jasn\u011b patrn\u00e1 z nastaven\u00ed finan\u010dn\u00edch tok\u016f. P\u0159esto\u017ee upfront platba ve v\u00fd\u0161i 115 milion\u016f USD p\u0159edstavuje pouze zlomek celkov\u00e9 \u010d\u00e1stky, slou\u017e\u00ed jako d\u016fle\u017eit\u00fd vstupn\u00ed kapit\u00e1l pro okam\u017eitou akceleraci spole\u010dn\u00fdch projekt\u016f. Zb\u00fdvaj\u00edc\u00edch 2,6 miliardy USD je p\u0159\u00edsn\u011b v\u00e1z\u00e1no na dosa\u017een\u00ed konkr\u00e9tn\u00edch regula\u010dn\u00edch miln\u00edk\u016f a komer\u010dn\u00edch \u00fasp\u011bch\u016f. Tento model chr\u00e1n\u00ed investora p\u0159ed rizikem ne\u00fasp\u011bchu v ran\u00fdch f\u00e1z\u00edch, zat\u00edmco pro Insilico Medicine otev\u00edr\u00e1 cestu k budouc\u00edm licen\u010dn\u00edm poplatk\u016fm z prodeje (royalties), co\u017e je pro biotechnologickou firmu nejcenn\u011bj\u0161\u00ed zdroj dlouhodob\u00e9ho pasivn\u00edho p\u0159\u00edjmu.<\/p>\n

28 d\u016fkaz\u016f technologick\u00e9 p\u0159evahy<\/strong><\/h3>\n

Kritici um\u011bl\u00e9 inteligence ve farmacii \u010dasto argumentuj\u00ed nedostatkem re\u00e1ln\u00fdch v\u00fdstup\u016f, Insilico Medicine v\u0161ak tyto pochybnosti vyvrac\u00ed konkr\u00e9tn\u00edmi daty. Spole\u010dnost pomoc\u00ed sv\u00fdch algoritm\u016f dosud navrhla minim\u00e1ln\u011b 28 l\u00e9\u010div, p\u0159i\u010dem\u017e t\u00e9m\u011b\u0159 polovina z nich se ji\u017e nach\u00e1z\u00ed v n\u00e1ro\u010dn\u00e9 klinick\u00e9 f\u00e1zi testov\u00e1n\u00ed. AI v tomto procesu p\u016fsob\u00ed jako katalyz\u00e1tor, kter\u00fd dok\u00e1\u017ee p\u0159edpov\u011bd\u011bt chov\u00e1n\u00ed molekul v lidsk\u00e9m t\u011ble d\u0159\u00edve, ne\u017e je vyroben prvn\u00ed gram l\u00e1tky. To dramaticky zvy\u0161uje efektivitu R&D (v\u00fdzkumu a v\u00fdvoje) a minimalizuje finan\u010dn\u00ed ztr\u00e1ty spojen\u00e9 s v\u00fdvojem slep\u00fdch uli\u010dek, kter\u00e9 jsou v tradi\u010dn\u00ed farmacii b\u011b\u017en\u00e9.<\/p>\n

Kdy\u017e se biologie setk\u00e1v\u00e1 s automatizac\u00ed<\/strong><\/h3>\n

\u00dasp\u011bch tohoto spojenectv\u00ed nestoj\u00ed pouze na AI k\u00f3du, ale p\u0159edev\u0161\u00edm na jeho propojen\u00ed s re\u00e1ln\u00fdm sv\u011btem. CEO spole\u010dnosti Insilico potvrdil, \u017ee Eli Lilly dominuje v integraci biologie, chemie a automatizace, a v n\u011bkter\u00fdch oblastech dokonce p\u0159ekon\u00e1v\u00e1 i samotn\u00e9 technologick\u00e9 firmy. Na druhou stranu se Insilico v r\u00e1mci dohody zapojuje do ekosyst\u00e9mu Lilly Gateway Labs, co\u017e je platforma ur\u010den\u00e1 k akceleraci biotechnologick\u00e9ho v\u00fdvoje. Tato infrastruktura umo\u017e\u0148uje digit\u00e1ln\u011b navr\u017een\u00fdm molekul\u00e1m okam\u017eit\u00fd p\u0159echod do automatizovan\u00fdch laborato\u0159\u00ed, \u010d\u00edm\u017e se uzav\u00edr\u00e1 cyklus mezi um\u011blou inteligenc\u00ed a re\u00e1lnou v\u00fdrobou.<\/p>\n

Tr\u017en\u00ed validace a geopolitick\u00fd rozm\u011br expanze<\/strong><\/h3>\n

Investo\u0159i na tento pokrok reaguj\u00ed zjevn\u011b optimisticky. Prosincov\u00e9 IPO spole\u010dnosti Insilico v Hongkongu a n\u00e1sledn\u00fd r\u016fst akci\u00ed o 50 % od za\u010d\u00e1tku roku (YTD) jasn\u011b demonstruje hlad trhu po firm\u00e1ch, kter\u00e9 maj\u00ed AI integrov\u00e1nu p\u0159\u00edmo ve sv\u00e9 DNA.* Z\u00e1rove\u0148 nelze p\u0159ehl\u00ed\u017eet geopolitickou strategii Eli Lilly \u2013 jejich pl\u00e1novan\u00e1 investice 3 miliardy USD v \u010c\u00edn\u011b v pr\u016fb\u011bhu n\u00e1sleduj\u00edc\u00edch 10 let nazna\u010duje snahu ovl\u00e1dnout trh, na kter\u00e9m zat\u00edm generuj\u00ed m\u00e9n\u011b ne\u017e 3 % sv\u00fdch tr\u017eeb. Pr\u00e1v\u011b kombinace AI a p\u0159\u00edstupu k \u010d\u00ednsk\u00fdm v\u00fdzkumn\u00fdm kapacit\u00e1m m\u016f\u017ee b\u00fdt pro spole\u010dnost kl\u00ed\u010dem k glob\u00e1ln\u00ed dominanci v n\u00e1sleduj\u00edc\u00ed dek\u00e1d\u011b.<\/p>\n

AI jako nov\u00e1 konkuren\u010dn\u00ed v\u00fdhoda<\/strong><\/h3>\n

Jsme sv\u011bdky transformace zdravotnictv\u00ed na technologick\u00e9 odv\u011btv\u00ed. Firmy, kter\u00e9 dnes neintegruj\u00ed generativn\u00ed AI do sv\u00e9ho j\u00e1dra, pravd\u011bpodobn\u011b nebudou schopny v bl\u00edzk\u00e9 budoucnosti konkurovat rychlost\u00ed v\u00fdvoje ani cenou fin\u00e1ln\u00edho produktu. Pro modern\u00edho investora je toto partnerstv\u00ed jasn\u00fdm sign\u00e1lem.<\/p>\n

Anna \u0160uhajdov\u00e1, p\u0159edsedkyn\u011b p\u0159edstavenstva <\/strong>CAPITAL MARKETS, o.c.p., a.s.<\/strong><\/a><\/h4>\n

*\u00dadaje, kter\u00e9 se t\u00fdkaj\u00ed minulosti, nejsou z\u00e1rukou budouc\u00edch v\u00fdnos\u016f.<\/p>\n

Upozorn\u011bn\u00ed! Tento marketingov\u00fd materi\u00e1l nen\u00ed a nesm\u00ed b\u00fdt ch\u00e1p\u00e1n jako investi\u010dn\u00ed poradenstv\u00ed. \u00dadaje t\u00fdkaj\u00edc\u00ed se minulosti nejsou z\u00e1rukou budouc\u00edch v\u00fdnos\u016f. Investov\u00e1n\u00ed v ciz\u00ed m\u011bn\u011b m\u016f\u017ee ovlivnit v\u00fdnosy v d\u016fsledku v\u00fdkyv\u016f. Ve\u0161ker\u00e9 obchody s cenn\u00fdmi pap\u00edry mohou v\u00e9st jak k zisk\u016fm, tak i ke ztr\u00e1t\u00e1m. V\u00fdhledov\u00e1 prohl\u00e1\u0161en\u00ed p\u0159edstavuj\u00ed p\u0159edpoklady a aktu\u00e1ln\u00ed o\u010dek\u00e1v\u00e1n\u00ed, kter\u00e1 nemus\u00ed b\u00fdt p\u0159esn\u00e1, nebo vych\u00e1zej\u00ed z aktu\u00e1ln\u00edho ekonomick\u00e9ho prost\u0159ed\u00ed, kter\u00e9 se m\u016f\u017ee zm\u011bnit. Tato prohl\u00e1\u0161en\u00ed nezaru\u010duj\u00ed budouc\u00ed v\u00fdkonnost. Spole\u010dnost CAPITAL MARKETS, o.c.p., a.s. je subjekt regulovan\u00fd N\u00e1rodn\u00ed bankou Slovenska.<\/p>\n

Zdroje:<\/strong><\/p>\n

https:\/\/www.cnbc.com\/2026\/03\/29\/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html<\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u00c9ra n\u00e1hodn\u00e9ho objevov\u00e1n\u00ed molekul a zdlouhav\u00fdch laboratorn\u00edch experiment\u016f metodou pokus-omyl se definitivn\u011b ch\u00fdl\u00ed ke konci….<\/p>\n","protected":false},"author":2,"featured_media":101029,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[6],"tags":[1042,286,8086],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/104005"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=104005"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/104005\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/101029"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=104005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=104005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=104005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}